EICHOR

Recruiting studies: Intravitreal Injection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Se
Phase 1/Phase 2 · 18 location(s) · Sanofi · NCT07215234 Age-related Macular Degeneration of Atrophic Type Treated With Umbilical Cord Blood Enriched With Platelet Plasma.
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06536062 Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Preventio
Phase 3 · 25 location(s) · Jaeb Center for Health Research · NCT05844982 Incidence of Hypoxia During Intravitreal Anti-VEGF (Vascular Endothelial Growth Factor) Injections for Retinopathy of Pr
Phase N/A · 1 location(s) · Minia University · NCT07701759 Efficacy and Safety Study of Bilateral IVT Injection of GS010 at Two Dose Levels in LHON Patients
Phase 2 · 1 location(s) · GenSight Biologics · NCT07303296 Eye Diseases "Treated" With Interoperable Medical Informatics
Phase N/A · 6 location(s) · University Hospital Muenster · NCT06810011 Patient Preferences on Same-day Bilateral Intravitreal Dexamethasone Injections
Phase N/A · 1 location(s) · Rigshospitalet, Denmark · NCT06894017 An Open-label, Dose-ascending Study of IGT001 for Retinitis Pigmentosa
Phase 1 · 1 location(s) · Shanghai General Hospital, Shanghai Jiao Tong University Sch · NCT06936787 Microinvasive Pars Plana Vitrectomy Combined ILM Peeling Versus Anti-VEGF Intravitreal Injection for Treatment-naïve Dia
NA · 1 location(s) · Tianjin Medical University Eye Hospital · NCT05728476 Atrophic Age-related Macular Degeneration Treated With Intravitreal Injections of Umbilical Cord Blood Platelet-rich Pla
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05706896 Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD)
Phase 1 · 2 location(s) · Benobio Co., Ltd. · NCT05803785 Acute Intra Ocular Pressure Monitoring After Aflibercept 8mg/0.07mL
NA · 1 location(s) · Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer · NCT06893965 Safety and Efficacy Study of PUMCH-E111 Injection in Subjects With RLBP1 Related Inherited Retinal Dystrophy
EARLY_Phase 1 · 1 location(s) · Peking Union Medical College Hospital · NCT07656753 Safety and Efficacy Study of PUMCH-E101 Injection in Subjects with RDH12 Retinopathy
EARLY_Phase 1 · 1 location(s) · Peking Union Medical College Hospital · NCT06749639 Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin
Phase 2/Phase 3 · 1 location(s) · Isfahan University of Medical Sciences · NCT06595355 Effect of Video Viewing on Intravitreal Injection Experience
NA · 1 location(s) · Second Affiliated Hospital, Zhejiang University, School of M · NCT07002372 Safety and Efficacy of Stem Cell Small Extracellular Vesicles in Patients With Retinitis Pigmentosa
Phase 1/Phase 2 · 1 location(s) · Mahidol University · NCT06242379 A Clinical Study Evaluating the Safety and Efficacy of SKG0106 in Patients With Neovascular Age-related Macular Degenera
Phase 1 · 3 location(s) · Youxin Chen · NCT06213038 Aflibercept in Recurrent or Persistent CNV
Phase N/A · 1 location(s) · Medical University of Vienna · NCT02669953 Mecobalamin Combined With Anti-VEGF Intravitreal Injection for Retinal Vein Occlusion Treatment
Phase 4 · 1 location(s) · First Affiliated Hospital of Chongqing Medical University · NCT07133438 Impact of Intravitreal Faricimab on Renal Function in Diabetic Patients
NA · 2 location(s) · University Hospital, Alexandroupolis · NCT06929507 Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients
Phase 1/Phase 2 · 3 location(s) · Ray Therapeutics, Inc. · NCT07439887 A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With D
Phase 1 · 10 location(s) · Genentech, Inc. · NCT07425522 Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)
Phase 1/Phase 2 · 9 location(s) · Skyline Therapeutics (US) Inc. · NCT05986864 A Study to Evaluate the Efficacy and Safety of IBI302inSubjects With nAMD
Phase 2 · 1 location(s) · Innovent Biologics Technology Limited (Shanghai R&D Center) · NCT07275840 Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macul
Phase 3 · 94 location(s) · 4D Molecular Therapeutics · NCT07064759 A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participant
Phase 3 · 36 location(s) · Amgen · NCT07614776 Intracameral Versus Intravitreal Bevacizumab Injection in NVG: RCT
NA · 1 location(s) · Prince of Songkla University · NCT03648814 Randomized Clinical Trial to Evaluate the Effect of Dapagliflozin in Patients With Diabetic Macular Edema
Phase 2 · 1 location(s) · Alexandria University · NCT06845163

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →